We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002409:SZSEJiangsu Yoke Technology Co., Ltd. Analysis

Data as of 2026-07-17 - not real-time

CN¥145.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Jiangsu Yoke Technology is trading at CNY 145, well below its 20‑day SMA of 188.62 but just above the 50‑day SMA of 145.69, indicating a short‑term price compression near a key moving‑average support. The stock shows a bullish overall trend direction yet the MACD is bearish (histogram ‑8.70) and RSI sits at 40.2, suggesting limited upside momentum and potential for further downside. Volatility is extreme at over 109 % for the past 30 days, while volume is on a decreasing trend, which raises execution risk. Fundamentally, the company is overvalued with a trailing PE of 68.4 versus an industry average of 33.2 and a P/B of 8.5. Revenue is contracting at ‑6.8 % YoY, though operating margins remain respectable (~18 %) and forward EPS is projected to rise to 3.5, implying earnings growth potential. The balance sheet shows ample cash (CNY 3.07 bn) but a high debt‑to‑equity of 38.4, and free cash flow is marginal, making the 0.4 % dividend yield modest yet sustainable at a 27 % payout. Given the mix of technical weakness, high valuation, and mixed fundamentals, the stock appears more suited for a cautious stance rather than aggressive buying.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering just above 50‑day SMA support
  • Bearish MACD and decreasing volume
  • Extreme short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant overvaluation relative to peers
  • Negative revenue growth offset by forward earnings upside
  • High debt level despite strong cash balance

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential secular growth in semiconductor equipment demand
  • Sustainable dividend with low payout ratio
  • Volatile price dynamics and elevated valuation metrics

Key Metrics & Analysis

Financial Health

Revenue Growth-6.80%
Profit Margin11.89%
P/E Ratio68.4
ROE10.29%
ROA4.94%
Debt/Equity38.42
P/B Ratio8.5
Op. Cash FlowCN¥1.0B
Free Cash FlowCN¥29.9M
Industry P/E33.2

Technical Analysis

TrendBullish
RSI40.2
SupportCN¥144.00
ResistanceCN¥246.44
MA 20CN¥188.62
MA 50CN¥145.69
MA 200CN¥97.49
MACDBearish
VolumeDecreasing
Fear & Greed Index88.61

Valuation

Target PriceCN¥99.00
Upside/Downside-31.72%
GradeOvervalued
TypeBlend
Dividend Yield0.40%

Risk Assessment

Beta0.21
Volatility109.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.